Willow Biosciences Inc. (TSX:WLLW)
Canada
· Delayed Price · Currency is CAD 0.0100
0.00 (0.00%)
Apr 4, 2025, 9:30 AM EST
Willow Biosciences Revenue
In the year 2024, Willow Biosciences had annual revenue of 4.66M CAD with 297.78% growth. Willow Biosciences had revenue of 1.88M in the quarter ending December 31, 2024, with 2,014.61% growth.
Revenue
4.66M
Revenue Growth
+297.78%
P/S Ratio
0.29
Revenue / Employee
245.37K
Employees
19
Market Cap
1.45M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.66M | 3.49M | 297.78% |
| Dec 31, 2023 | 1.17M | 351.00K | 42.75% |
| Dec 31, 2022 | 821.00K | 688.00K | 517.29% |
| Dec 31, 2021 | 133.00K | 123.00K | 1,230.00% |
| Dec 31, 2020 | 10.00K | 5.00K | 100.00% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Thumb Industries | 1.64B |
| dentalcorp Holdings | 1.55B |
| Sienna Senior Living | 893.16M |
| WELL Health Technologies | 957.69M |
| Extendicare | 1.47B |
| Trulieve Cannabis | 1.71B |
| Cronos Group | 169.23M |
| Curaleaf Holdings | 1.93B |